R/C Glycopress F: Glycopyrrolate & Formoterol Fumarate Inhalation

May 31, 2024

R/C GLYCOPRESS F

Glycopyrrolate and formoterol fumarate powder for inhalation

R/C GLYCOPRESS F combination of Glycopyrrolate and formoterol fumarate powder for inhalation is a combination medication used in the management of chronic obstructive pulmonary disease (COPD). This dual-action therapy combines a long-acting muscarinic antagonist (LAMA) and a long-acting beta-agonist (LABA) to provide comprehensive relief from respiratory symptoms.

Uses :

Chronic Obstructive Pulmonary Disease (COPD): This medication is primarily used to manage COPD, improving lung function and reducing exacerbations.
Symptom Relief: It helps alleviate symptoms such as breathlessness, wheezing, and chronic cough.

Dosage :

Standard Dosage: The usual recommended dose is two inhalations twice daily, taken at the same times each day.
Adjustment: Dosage adjustments may be necessary based on individual response and the severity of the condition, as advised by a healthcare provider.

Side Effects :

Common Side Effects:
- Dry mouth
- Hoarseness
- Cough
Serious Side Effects:
- Increased heart rate
- High blood pressure
- Allergic reactions

Precautions :

Monitoring: Regular monitoring of lung function and cardiovascular health is recommended during treatment.
Caution: Use with caution in patients with a history of heart disease, hypertension, or severe allergies.

Mechanism of Action :

Glycopyrrolate: Acts as a long-acting muscarinic antagonist (LAMA), relaxing the muscles around the airways and preventing bronchospasm.
Formoterol Fumarate: A long-acting beta-agonist (LABA) that relaxes bronchial smooth muscles, enhancing airflow and breathing.

Conclusion :

Glycopyrrolate and formoterol fumarate powder for inhalation provides a comprehensive approach to managing COPD. By combining the benefits of a LAMA and a LABA, it helps improve lung function, reduce symptoms, and enhance the quality of life for patients. Adhering to prescribed dosages and taking necessary precautions can help maximize benefits and minimize risks. Steris Healthcare Pvt Ltd, established in February 2018 by seasoned professionals in the pharmaceutical sector, operates under the name Sterispharma. Headquartered in Navi Mumbai, the company is certified by WHO, GMP, and ISO. Sterispharma is dedicated to providing high-quality medications at affordable prices across India, adhering to stringent WHO guidelines. They offer an online pharmacy platform for easy medicine purchases and home delivery. The company's mission is to deliver a diverse range of healthcare products catering to the varied needs of the medical community. From advanced treatments and rare condition medications to essential health supplies, Sterispharma aims to meet the extensive demands of the healthcare industry. Their product range covers numerous health fields, including Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.